Low to Moderate Dose Anthracycline-Based Chemotherapy is Associated with Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease

OBJECTIVE: To determine if low to moderate doses of anthracycline-based chemotherapy (Anth-bC) are associated with subclinical cardiovascular (CV) injury. BACKGROUND: Cancer survivors that receive Anth-bC experience premature CV events. It is unknown whether low to moderate doses of anthracyclines a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Drafts, Brandon C., Twomley, Katie M., D’Agostino, Ralph, Lawrence, Julia, Avis, Nancy, Ellis, Leslie R., Thohan, Vinay, Jordan, Jennifer, Melin, Susan A., Torti, Frank M., Little, William C., Hamilton, Craig A., Hundley, W. Gregory
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3745801/
https://ncbi.nlm.nih.gov/pubmed/23643285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmg.2012.11.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars